Lyra Eyes US Filing For LYR-210 After Surprise ENLIGHTEN 2 Win

Non-Polyp Rhinosinusitis Targeted Initially

 
• By Sushmita Panda
  
Lyra Therapeutics
Lyra Eyes US Filing For Drug-Eluting Implant For Non-Polyp Rhinosinusitis (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from Scrip